Open issues in Mucopolysaccharidosis type I-Hurler

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
leukodystrophy 1 endocrinologydiseases
lysosomal storage disease 1 endocrinologydiseases
metachromatic leukodystrophy 1 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
leukodystrophy 15763 therapy) following conditioning with busulfan resulted in supra-normal levels of enzyme in metachromatic leukodystrophy , an inherited lysosomal storage disease caused by arylsulfatase A deficiency [[27]]. Whether supra-normal
lysosomal storage disease 15792 with busulfan resulted in supra-normal levels of enzyme in metachromatic leukodystrophy, an inherited lysosomal storage disease caused by arylsulfatase A deficiency [[27]]. Whether supra-normal levels of IDUA in MPS I patients will
metachromatic leukodystrophy 15749 (ex-vivo gene therapy) following conditioning with busulfan resulted in supra-normal levels of enzyme in metachromatic leukodystrophy , an inherited lysosomal storage disease caused by arylsulfatase A deficiency [[27]]. Whether supra-normal

You must be authorized to submit a review.